Research leaders from the University of 欧美高清 and pharmaceutical company GSK have been named the winners of a prestigious prize by the Royal Society of Chemistry (RSC).
The team has won the RSC鈥檚 Industry-Academia Collaboration Award, as part of a series of awards celebrating the most exciting chemical science taking place today.
The prize was awarded for the creation of a sustained partnership which has driven a culture of research and training excellence and created a flow of skilled personnel to enhance capabilities within the sector.
The collaborative framework sees both GSK employees and non-employee cohorts work towards an MPhil/PhD degree through active drug discovery and development projects within GSK or 欧美高清 laboratories, with joint industry and academic supervision.
On receiving the prize, Professor William J Kerr, Collaborative Programme Director, and Deputy Associate Principal (Research & Knowledge Exchange) at the University of 欧美高清 said: 鈥淐ollaboration with industry is at the heart of our operations at 欧美高清 and we are both delighted and honoured that our 欧美高清-GlaxoSmithKline research degree programmes have been recognised as worthy of the RSC Industry-Academia Collaboration Award.
鈥淭he establishment of a rich array of pharma-aligned postgraduate students and associated research projects has resulted from a series of sustained and reciprocally beneficial relationships over a large number of years, where deep mutual trust has been established, alongside clear appreciation of the respective demands, drivers, and requirements of each partner.鈥�
Professor Harry A Kelly, Collaborative Programme Director, GlaxoSmithKline said: 鈥淭he significance and reach of the collaboration has gone well beyond the initial aims. This award is testament to the committed and talented research supervisors and students we have across the partnership, who vigorously employ two-directional knowledge exchange to maximise innovation and impact within GSK and all as related to the wider national and international healthcare sector.鈥�
Dave Allen, Senior Vice-President and Chief Chemist, GlaxoSmithKline said: 鈥淭hese programmes have led to enhanced levels of project-relevant scientific knowledge, advanced thinking, and overall scientific rigour. The established collaborative framework has had a positive impact on and is now contributing extensively to overall organisational learning within GSK.鈥�
RSC Chief Executive Dr Helen Pain said: 鈥淎ll of us have experienced tremendous challenges in the last year and the chemical sciences community has been integral to how the world has responded on a number of levels. From developing vaccines for COVID-19 to continuing to work towards a more sustainable world 鈥� the contribution of chemical scientists has never been more tangible or important.
鈥淚n a recent review of our recognition portfolio, we committed to ensuring that our prizes reflected the incredible diversity and excellence of chemistry being carried out today. The team鈥檚 work is a prime example of what we are so passionate about and we are proud to recognise their contribution with this prize.鈥�
The Research and Innovation Prizes 鈥� of which the Industry-Academia Collaboration Award is one 鈥� celebrate brilliant individuals across industry and academia. They include prizes for those at different career stages in general chemistry and for those working in specific fields, as well as interdisciplinary prizes and prizes for those in specific roles.
The announcement of this Industry-Academia Collaboration Award coincides with another RSC award for 欧美高清 鈥� the Analytical Division mid-career Award, presented to Professor Karen Faulds, of the University鈥檚 Department of Pure and Applied Chemistry.
More than 50 winners of RSC prizes have gone on to become Nobel prizewinners, including 2019 Nobel laureate John B Goodenough.